Skip to main content

Aclaris Therapeutics, Inc.

ACRS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001557746

No open-market purchases or sales by Aclaris Therapeutics, Inc. insiders were filed in the last 90 days; 148 institutions reported holding it in 13F filings for Q2 2026, worth $630.0M in total; no superinvestor holds it.

13F holders, Q3 2021

Institutional positions in Aclaris Therapeutics, Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
126
−1 vs. Q2 2021
Shares held
56.8M
+817.7K (+1.5%) vs. Q2 2021
Total value
$1.02B
+$39.4M (+4.0%) vs. Q2 2021
New holders
21
51 more added
Sold out
22
36 more reduced

1 institution that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q2 2021: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting ACRS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ3 2021: 126 institutions
Q1 2021: 97 institutionsQ2 2021: 128 institutionsQ3 2021: 126 institutionsQ4 2021: 133 institutionsQ1 2022: 110 institutionsQ2 2022: 115 institutionsQ3 2022: 127 institutionsQ4 2022: 128 institutionsQ1 2023: 149 institutionsQ2 2023: 133 institutionsQ3 2023: 138 institutionsQ4 2023: 107 institutionsQ1 2024: 98 institutionsQ2 2024: 98 institutionsQ3 2024: 81 institutionsQ4 2024: 98 institutionsQ1 2025: 109 institutionsQ2 2025: 96 institutionsQ3 2025: 103 institutionsQ4 2025: 122 institutionsQ1 2026: 136 institutionsQ2 2026: 148 institutions
Value heldQ3 2021: $1.02B
Q1 2021: $1.14BQ2 2021: $983.4MQ3 2021: $1.02BQ4 2021: $814.9MQ1 2022: $1.02BQ2 2022: $883.3MQ3 2022: $1.00BQ4 2022: $1.04BQ1 2023: $579.3MQ2 2023: $737.2MQ3 2023: $480.0MQ4 2023: $61.4MQ1 2024: $67.5MQ2 2024: $58.1MQ3 2024: $58.5MQ4 2024: $217.0MQ1 2025: $143.8MQ2 2025: $130.4MQ3 2025: $162.8MQ4 2025: $252.1MQ1 2026: $409.4MQ2 2026: $630.0M
Institutions holding ACRS and their total value by quarter
QuarterHoldersValue
Q2 2026148$630.0M
Q1 2026136$409.4M
Q4 2025122$252.1M
Q3 2025103$162.8M
Q2 202596$130.4M
Q1 2025109$143.8M
Q4 202498$217.0M
Q3 202481$58.5M
Q2 202498$58.1M
Q1 202498$67.5M
Q4 2023107$61.4M
Q3 2023138$480.0M
Q2 2023133$737.2M
Q1 2023149$579.3M
Q4 2022128$1.04B
Q3 2022127$1.00B
Q2 2022115$883.3M
Q1 2022110$1.02B
Q4 2021133$814.9M
Q3 2021126$1.02B
Q2 2021128$983.4M
Q1 202197$1.14B

Institutions, Q3 2021

Shares, value and share of portfolio for each institution holding Aclaris Therapeutics, Inc.; share changes are against Q2 2021.

Institutions holding ACRS in Q3 2021
InstitutionSharesValue% of portfolioChange in sharesAction
Cherry Creek Investment Advisors, Inc.12,515$225.0K0.15%+12,515New
Arizona State Retirement System12,084$218.0K0.00%+12,084New
Baker Tilly Wealth Management, LLC11,773$212.0K0.03%+34+0.3%Added
Tudor Investment Corp Et Al10,539$190.0K0.00%+10,539New
Blair William & Co10,050$181.0K0.00%+10,050New
BNP Paribas Arbitrage, SA9,029$162.5K0.00%+7,373+445.2%Added
STRS Ohio6,700$120.0K0.00%−10,200−60.4%Reduced
Tower Research Capital LLC (TRC)6,670$120.0K0.00%−1,787−21.1%Reduced
Group One Trading, L.P.6,042$109.0K0.00%+4,273+241.5%Added
Royal Bank of Canada5,146$93.0K0.00%+2,172+73.0%Added
First Mercantile Trust Co4,433$80.0K0.01%−279−5.9%Reduced
Simplex Trading, LLC4,243$73.0K0.00%−296−6.5%Reduced
Ameritas Investment Partners, Inc.3,979$72.0K0.00%+575+16.9%Added
Zurcher Kantonalbank (Zurich Cantonalbank)3,211$58.0K0.00%+3,211New
Meeder Asset Management Inc2,383$43.0K0.00%+2,383New
Great West Life Assurance Co1,944$35.0K0.00%00.0%Unchanged
UBS Group AG1,650$30.0K0.00%−1,249−43.1%Reduced
Macquarie Group Ltd1,568$28.0K0.00%+1,568New
Quantbot Technologies LP765$13.0K0.00%+765New
Northwestern Mutual Wealth Management Co500$9.00K0.00%00.0%Unchanged
O'Shaughnessy Asset Management, LLC288$5.00K0.00%−35−10.8%Reduced
TCI Wealth Advisors, Inc.203$4.00K0.00%+203New
Brewin Dolphin Ltd195$3.51K0.00%00.0%Unchanged
Truvestments Capital LLC150$3.00K0.00%00.0%Unchanged
Berman Capital Advisors, LLC170$3.00K0.00%+170New
Harbour Investments, Inc.100$2.00K0.00%00.0%Unchanged
Logos Global Management LP0$00.00%−675,000−100.0%Sold out
Bridgeway Capital Management, LLC0$00.00%−135,000−100.0%Sold out
Pinz Capital Management, LP0$00.00%−114,835−100.0%Sold out
DAFNA Capital Management LLC0$00.00%−100,000−100.0%Sold out
Monashee Investment Management LLC0$00.00%−100,000−100.0%Sold out
Jefferies Group LLC0$00.00%−40,063−100.0%Sold out
Old Mission Capital LLC0$00.00%−37,334−100.0%Sold out
Jump Financial, LLC0$00.00%−34,739−100.0%Sold out
ExodusPoint Capital Management, LP0$00.00%−28,975−100.0%Sold out
Engineers Gate Manager LP0$00.00%−24,532−100.0%Sold out
Dynamic Technology Lab Private Ltd0$00.00%−24,061−100.0%Sold out
Boothbay Fund Management, LLC0$00.00%−19,174−100.0%Sold out
Quantitative Systematic Strategies LLC0$00.00%−13,658−100.0%Sold out
Trexquant Investment LP0$00.00%−13,555−100.0%Sold out
Twin Securities, Inc.0$00.00%−12,500−100.0%Sold out
ProShare Advisors LLC0$00.00%−11,264−100.0%Sold out
Advisor Group Holdings, Inc.0$00.00%−3,195−100.0%Sold out
Brown Brothers Harriman & Co0$00.00%−2,588−100.0%Sold out
Point72 Hong Kong Ltd0$00.00%−2,378−100.0%Sold out
Panagora Asset Management Inc0$00.00%−749−100.0%Sold out
Cutler Group LP0$00.00%−600−100.0%Sold out
Parallel Advisors, LLC0$00.00%−100−100.0%Sold out
QS Investors, LLC––––Not filed